Microbiological Profile of Periprosthetic Infections Following Femoral Fracture: A Retrospective Analysis

Luca Bianco Prevot1, Edoardo Verme2, Livio Pietro Tronconi3,4

  • 1Department of Biomedical Sciences and Public Health, University "Politecnica Delle Marche" of Ancona, 60124 Ancona, Italy.

Insights

Implant infections after femoral fractures in elderly patients are distinct from elective joint replacements, often involving multidrug-resistant bacteria and leading to high mortality. Tailored strategies are crucial for this frail population.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Geriatric Medicine

Background:

  • Implant-related infections post-femoral fracture surgery pose significant risks in elderly patients.
  • Existing data on periprosthetic joint infection (PJI) primarily from elective arthroplasty do not fully represent fracture populations.
  • Understanding specific microbial profiles and clinical features is vital for this unique patient group.

Purpose of the Study:

  • To investigate the microbiological landscape of implant-related infections following proximal femoral fracture surgery.
  • To characterize the clinical presentation and outcomes of these infections in elderly patients.

Main Methods:

  • Retrospective observational study of 20 patients (≥70 years) with implant-related infections after proximal femoral fracture surgery (2020-2025).
  • Inclusion criteria: Charlson Comorbidity Index ≥ 4, infection within one year of surgery.
  • Data reviewed: clinical, surgical, microbiological, and antibiotic therapy.

Main Results:

  • The cohort (mean age 82.4 years) exhibited a high comorbidity burden (mean Charlson index 4.8).
  • Staphylococcus aureus was the most common pathogen (25.9%), with 85% methicillin-resistant strains.
  • Polymicrobial infections occurred in 25% of patients, and one-year mortality was 25%.

Conclusions:

  • Implant-related infections post-femoral fracture surgery are a distinct entity from elective PJI.
  • Frail elderly patients with these infections show a higher prevalence of multidrug-resistant organisms.
  • Tailored preventive and therapeutic strategies are essential for this high-risk demographic.

Related Concept Videos